David Rodman Malcom Insider Trading Activity

Corporate InsiderChief Medical Officer · CIK 1672659

35

Total trades

$14.1M

Total volume

May 18, 2026

Last activity

MLYS

Mineralys Therapeutics, Inc.

David Rodman Malcom has been net-selling over the last 12 months with 0 purchases and 35 sales across 1 company.

MLYS is the most-traded position with 35 trades. The largest single transaction was a sale of MLYS for $4.8M on Jan 5, 2026.

Performance Scorecard

Forward stock performance after each transaction by David Rodman Malcom. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days—-2.4%71%31
90 days—-18.7%82%22
120 days—-30.5%79%14

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

MLYS · Mineralys Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when David Rodman Malcom bought and sold MLYS.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEROLE
May 18, 2026MLYSSell417$27.55$11KChief Medical Officer
May 13, 2026MLYSSell14,056$28.58$402KChief Medical Officer
May 12, 2026MLYSSell6,348$29.36$186KChief Medical Officer
May 11, 2026MLYSSell2,171$29.71$65KChief Medical Officer
Apr 17, 2026MLYSSell416$31.33$13KChief Medical Officer
Apr 15, 2026MLYSSell6,348$27.66$176KChief Medical Officer
Apr 13, 2026MLYSSell14,058$26.54$373KChief Medical Officer
Apr 9, 2026MLYSSell2,170$27.38$59KChief Medical Officer
Mar 17, 2026MLYSSell417$25.65$11KChief Medical Officer
Mar 13, 2026MLYSSell10,726$25.91$278KChief Medical Officer
Mar 13, 2026MLYSSell3,079$27.37$84KChief Medical Officer
Mar 13, 2026MLYSSell253$27.82$7KChief Medical Officer
Mar 12, 2026MLYSSell6,348$27.37$174KChief Medical Officer
Mar 9, 2026MLYSSell2,171$26.84$58KChief Medical Officer
Feb 17, 2026MLYSSell417$27.59$12KChief Medical Officer
Feb 13, 2026MLYSSell3,541$27.33$97KChief Medical Officer
Feb 13, 2026MLYSSell4,166$27.33$114KChief Medical Officer
Feb 13, 2026MLYSSell6,348$27.58$175KChief Medical Officer
Feb 12, 2026MLYSSell5,828$28.94$169KChief Medical Officer
Feb 12, 2026MLYSSell521$29.64$15KChief Medical Officer
Feb 9, 2026MLYSSell2,171$30.21$66KChief Medical Officer
Jan 20, 2026MLYSSell416$32.10$13KChief Medical Officer
Jan 14, 2026MLYSSell11,367$32.61$371KChief Medical Officer
Jan 13, 2026MLYSSell7,709$32.75$252KChief Medical Officer
Jan 12, 2026MLYSSell6,348$32.32$205KChief Medical Officer
Jan 9, 2026MLYSSell2,170$33.27$72KChief Medical Officer
Jan 5, 2026MLYSSell139,245$34.83$4.8MChief Medical Officer
Jan 5, 2026MLYSSell53,470$35.53$1.9MChief Medical Officer
Jan 2, 2026MLYSSell70,037$35.87$2.5MChief Medical Officer
Oct 15, 2025MLYSSell10,369$43.01$446KChief Medical Officer
Sep 15, 2025MLYSSell9,302$35.90$334KChief Medical Officer
Sep 15, 2025MLYSSell2,065$36.47$75KChief Medical Officer
Aug 13, 2025MLYSSell11,365$12.93$147KChief Medical Officer
Jul 14, 2025MLYSSell11,366$14.59$166KChief Medical Officer
Jun 13, 2025MLYSSell11,366$14.60$166KChief Medical Officer

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
MLYSMineralys Therapeutics, Inc.35$14.1M

Other insiders at Mineralys Therapeutics, Inc.

5 other tracked filers at MLYS.

Levy Adam Scott

CFO

17

Trades

Congleton Jon

CEO

15

Trades

Gold Alexander M

Director

5

Trades

RA Capital Management, L.P.Institutional

Director

3

Trades

Karydas Daphne

Director

3

Trades